1 / 1

M.J. Miranda , M. Atkins, L. Sahlholdt, T. Hoffmann, H Nielsen, M Mortensen, M.Nikanorova

Ketogenic diet (KD) in the treatment of encephalopathy with continuous spike and waves during slow sleep (CSWS): a pilot study. M.J. Miranda , M. Atkins, L. Sahlholdt, T. Hoffmann, H Nielsen, M Mortensen, M.Nikanorova ¹ Danish Epilepsy Centre, Dianalund, Denmark. Introduction

holleb
Télécharger la présentation

M.J. Miranda , M. Atkins, L. Sahlholdt, T. Hoffmann, H Nielsen, M Mortensen, M.Nikanorova

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Ketogenic diet (KD) in the treatment of encephalopathy with continuous spike and waves during slow sleep (CSWS): a pilot study M.J. Miranda, M. Atkins, L. Sahlholdt, T. Hoffmann, H Nielsen, M Mortensen, M.Nikanorova ¹Danish Epilepsy Centre, Dianalund, Denmark • Introduction • Epilepsy syndromes with continuous spikes and waves during slow sleep (CSWS) are defined as “a cognitive or behavioural impairment acquired during childhood, associated with a strong activation of the interictal epileptiform discharges during non-REM (NREM) sleep”¹ • Treatment with Antiepileptic drugs (AEDs) as Valproate, Benzodiazepines, Sultiam, Ethosuximide and more recently Levetiracetam² as well as Steroids might be helpful but the effect is often intermittent • In a proportion of children, CSWS is resistant to all AEDs with high risk of cognitive deterioration³ • Aim • To evaluate the effectiveness of KD for treating medically refractory CSWS, regarding tolerability, electro-clinical features and cognitive functions. • Patients and methods • The first 4 patients, fulfilling clinical and • electrophysiological criteria4 (at least 85% interictal discharges in NREM sleep) of CSWS are presented. • CSWS was refractory to all tried medications • Neuropsychological test (WPPSI/ WISC) are available • before KD and at follow up • 24-hour EEG recording is available before start of KD • and at follow up, every 3-6 mo. EEG from patient 3 EEG Table 2. Results *n/a= no available Table 1. Patient data • Results • EEG characteristics (% discharges in NREM sleep) seem to • fluctuate independently to KD • No significant improvement in EEG or cognitive tests were found • Conclusions • KD does not seem to be effective in the treatment • of encephalopathy with CSWS • Further studies with more included patients are needed . References ¹Van Bogaert P et al,2006 Acta Neurol Belg ²Aeby A et al, 2005 Epilepsia ³ Veggiotti P ,2002 Epileptic Disord. 4 ”Epileptic syndromes in infancy, childhood and adolescence”, 2005, Ed. Roger M, Wolf P et al. r KD characteristics Classical ketogenic diet with ratios 2.5-4.0: 1 were used with good acceptance and tolerability marimn@vestamt.dk marnik@vestamt.dk

More Related